Artificial Intelligence (AI) In Drug Discovery Market Growth Is Driven At A 30% Rate With Increasing Adoption Of Cloud-Based Applications And Services…

LONDON, May 24, 2022 (GLOBE NEWSWIRE) -- According to The Business Research Companys research report on the artificial intelligence (AI) in drug discovery market, the rising adoption of cloud-based applications and services by pharmaceutical companies will contribute to the growth of AI in the drug discovery market. Among the various end-users of cloud-based drug discovery platforms, pharmaceutical vendors are likely to be major stakeholders, holding a high-value share of the global cloud-based drug discovery platform market. An opportunity analysis of the global market reveals that leading software vendors have already adopted cloud-based drug discovery platforms to facilitate seamless research and development processes. Moreover, the cloud-based drug discovery platform revolution will witness significant growth in the coming years, thereby creating better opportunities for software vendors for growth and expansion. For example, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced in December 2021 that it is collaborating with Pfizer to develop innovative, cloud-based solutions that have the potential to improve how new medicines are developed, manufactured, and distributed for clinical trials. The companies are exploring these advances through their newly created Pfizer Amazon Collaboration Team (PACT) initiative, which applies AWS capabilities in analytics, machine learning, compute, storage, security, and cloud data warehousing to Pfizer laboratory, clinical manufacturing, and clinical supply chain efforts. Thus, the increasing adoption of cloud-based applications and services by pharmaceutical companies will contribute positively to the AI drug discovery market size.

Request for a sample of the global artificial intelligence (AI) in drug discovery market report

The global artificial intelligence in drug discovery market size is expected to grow from $0.79 billion in 2021 to $1.04 billion in 2022 at a compound annual growth rate (CAGR) of 31.6%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The AI in drug discovery market is expected to reach $2.99 billion in 2026 at a CAGR of 30.2%.

Use of AI through Machine Learning (ML) is a trend in assessing pre-clinical studies during the drug development process. Pre-clinical studies are non-clinical studies for novel drug substances to establish clinical efficacy and safety in a controlled environment before testing with a final target population. ML modelling pharmacokinetic (PK) and pharmacodynamic (PD) methodologies are applied in in-vitro and preclinical PK studies to successfully anticipate the dose concentration response relationship of pipeline assets. In addition, deep learning methodologies are employed as In-Silico methods for successfully predicting the therapeutic/pharmacological properties of novel molecules by utilizing transcriptomic data, which includes various biological systems and controlled conditions. Besides the drug discovery market, machine learning technology finds its application in the AI in medical diagnostics market as well as AI in medical imaging market.

Major players in the artificial intelligence for drug discovery and development market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, and BIOAGE.

The global artificial intelligence in drug discovery market report is segmented by technology into deep learning, machine learning; by drug type into small molecule, large molecules; by disease type into metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, others; by end-users into pharmaceutical companies, biopharmaceutical companies, academic and research institutes, others.

In 2021, North America was the largest region in the artificial intelligence (AI) in drug discovery market. It was followed by the Asia-Pacific, Western Europe, and then the other regions. The regions covered in the AI in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022 Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provide artificial intelligence (AI) in drug discovery market overviews, artificial intelligence (AI) in drug discovery market analyze and forecast market size and growth for the whole market, artificial intelligence (AI) in drug discovery market segments and geographies, artificial intelligence (AI) in drug discovery market trends, artificial intelligence (AI) in drug discovery market drivers, artificial intelligence (AI) in drug discovery market restraints, artificial intelligence (AI) in drug discovery market leading competitors revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.

The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors approaches.

Not the market you are looking for? Check out some similar market intelligence reports:

AI In Pharma Global Market Report 2022 By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research And Development, Epidemic Prediction) Market Size, Trends, And Global Forecast 2022-2026

Artificial Intelligence In Healthcare Global Market Report 2022 By Offering (Hardware, Software), By Algorithms (Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing), By Application (Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Fraud Detection, Dosage Error Reduction, Clinical Trial Participant Identifier, Preliminary Diagnosis), By End User(Hospitals And Diagnostic Centers, Pharmaceutical And Biopharmaceutical Companies, Healthcare Payers, Patients) Market Size, Trends, And Global Forecast 2022-2026

Cloud Services Global Market Report 2022 By Type (Software As A Service (SaaS), Platform As A Service (PaaS), Infrastructure As A Service (IaaS), Business Process As A Service (BPaaS)), By End-User Industry (BFSI, Media And Entertainment, IT And Telecommunications, Energy And Utilities, Government And Public Sector, Retail And Consumer Goods, Manufacturing), By Application (Storage, Backup, And Disaster Recovery, Application Development And Testing, Database Management, Business Analytics, Integration And Orchestration, Customer Relationship Management), By Deployment Model (Public Cloud, Private Cloud, Hybrid Cloud), By Organization Size (Large Enterprises, Small And Medium Enterprises) Market Size, Trends, And Global Forecast 2022-2026

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The Worlds Most Comprehensive Database

The Business Research Companys flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Read more:

Artificial Intelligence (AI) In Drug Discovery Market Growth Is Driven At A 30% Rate With Increasing Adoption Of Cloud-Based Applications And Services...